Abstract | BACKGROUND: METHODS: We retrospectively examined 93 patients who underwent atrial fibrillation ablation at Kariya Toyoda General Hospital between December 2017 and April 2019 and investigated differences in the outcomes, such as depth of sedation and postoperative adverse events between the buprenorphine hydrochloride (n = 46) and fentanyl citrate (n = 47) groups. RESULTS: The depth of sedation was similar between the two groups, without significant between-group differences in postoperative vomiting. The number of additional injections of thiamylal sodium to manage discomfort and pain during ablation were significantly lower in the fentanyl group. Additionally, the cumulative area product, cumulative total air kerma, 1-year postoperative atrial fibrillation recurrence rate, and postoperative complications were not significantly different between the two groups. CONCLUSIONS:
|
Authors | Teruhisa Kinoshita, Mitsunori Harada, Norio Takimoto, Daichi Shibata, Takashi Sakakibara, Mamoru Adachi |
Journal | Journal of pharmaceutical health care and sciences
(J Pharm Health Care Sci)
Vol. 7
Issue 1
Pg. 2
(Jan 04 2021)
ISSN: 2055-0294 [Print] England |
PMID | 33397507
(Publication Type: Journal Article)
|